The budget impact of introducing the OMNI® surgical system to a United States health plan for managing mild-to-moderate primary open-angle glaucoma

References

• Inoue K, Shiokawa M, Higa R, et al. Adverse periocular reactions to five types of prostaglandin analogs. Eye (Lond). 2012 Nov;26(11):1465–1472.
   PubMed Web of Science ®Google Scholar
• Inoue K. Managing adverse effects of glaucoma medications. Clin Ophthalmol. 2014;8:903–913.
   PubMedGoogle Scholar
• Friedman DS, Wolfs RC, O‘Colmain BJ, et al. Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122(4):532. doi: 10.1001/archopht.122.4.532:
   PubMedGoogle Scholar
• Minckler DS, Francis BA, Hodapp EA, et al. Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology. Ophthalmol. 2008 Jun;115(6):1089–1098.
   PubMed Web of Science ®Google Scholar
• Gedde SJ, Vinod K, Wright MM, et al. Primary open-angle glaucoma preferred practice pattern®. Ophthalmol. 2021;128(1):71–P150. DOI:10.1016/j.ophtha.2020.10.022
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901–1911.
   PubMed Web of Science ®Google Scholar
• Prager AJ, Liebmann JM, Cioffi GA, et al. Self-reported function, health resource use, and total health care costs among medicare beneficiaries with glaucoma. JAMA Ophthalmol. 2016;134(4):357–365. doi: 10.1001/jamaophthalmol.2015.5479. PMID: 26747060.
   PubMed Web of Science ®Google Scholar
• Assi L, Chamseddine F, Ibrahim P, et al. A global assessment of eye health and quality of life: a systematic review of systematic reviews. JAMA Ophthalmol. 2021;139(5):526–541. DOI:10.1001/jamaophthalmol.2021.0146
   PubMed Web of Science ®Google Scholar
• Varma R, Lee PP, Goldberg I, et al. An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol. 2011;152(4):515–522. DOI:10.1016/j.ajo.2011.06.004
   PubMed Web of Science ®Google Scholar
• Sight Sciences Inc. OMNI® Surgical System. 2022; Accessed 16 Jan, 2022. https://www.sightsciences.com/ous/sight-sciences-introduces-the-next-generation-omni-surgical-system-for/microinvasive-glaucoma-surgery/
   Google Scholar
• Sight Sciences Inc. Sight Sciences introduces the next-generation OMNI® Surgical System for microinvasive glaucoma surgery. 2020; https://www.sightsciences.com/ous/sight-sciences-introduces-the-next-generation-omni-surgical-system-for-microinvasive-glaucoma-surgery/. Accessed 11 Oct, 2021.
   Google Scholar
• Vold SD, Williamson BK, Hirsch L, et al. Canaloplasty and Trabeculotomy with the OMNI System in Pseudophakic Patients with Open-Angle Glaucoma: the ROMEO Study. Ophthalmol Glaucoma. 2021;4(2):173–181. DOI:10.1016/j.ogla.2020.10.001
   PubMedGoogle Scholar
• Gallardo MJ, Sarkisian SR Jr., Vold SD, et al. Canaloplasty and Trabeculotomy Combined with Phacoemulsification in Open-Angle Glaucoma: interim Results from the GEMINI Study. Clin Ophthalmol. 2021;15:481–489.
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Salman M, Lee PP, et al. Cost-Utility Analysis of Glaucoma Medication Adherence. Ophthalmol. 2020;127(5):589–598. DOI:10.1016/j.ophtha.2019.09.041
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Woodward MA, Niziol LM, et al. Brand Medications and Medicare Part D: how Eye Care Providers’ Prescribing Patterns Influence Costs. Ophthalmol. 2018;125(3):332–339. DOI:10.1016/j.ophtha.2017.05.024
   PubMed Web of Science ®Google Scholar
• Global Medicine Database. Drug Database and Medicine Price Index. 2022. https://www.pharma14.com/. Accessed 16 Jan 2022.
   Google Scholar
• Grabska-Liberek I, Duda P, Rogowska M, et al. 12-month interim results of a prospective study of patients with mild to moderate open-angle glaucoma undergoing combined viscodilation of Schlemm’s canal and collector channels and 360° trabeculotomy as a standalone procedure or combined with cataract surgery. Eur J Ophthalmol. 2022;32(1):309–315. DOI:10.1177/1120672121998234
   PubMed Web of Science ®Google Scholar
• Salimi A, Clement C, Shiu M, et al. Second-Generation Trabecular Micro-Bypass (iStent inject) with Cataract Surgery in Eyes with Normal-Tension Glaucoma: one-Year Outcomes of a Multi-Centre Study. Ophthalmol Ther. 2020;9(3):585–596. DOI:10.1007/s40123-020-00266-6
   PubMed Web of Science ®Google Scholar
• Perez-Torregrosa VT, Olate-Perez A, Cerda-Ibanez M, et al. Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions. Archivos de la Sociedad Española de Oftalmología (English Edition). 2016;91(9):415–421. DOI:10.1016/j.oftale.2016.05.004
   Google Scholar
• Khan M, Saheb H, Neelakantan A, et al. Efficacy and safety of combined cataract surgery with 2 trabecular microbypass stents versus ab interno trabeculotomy. J Cataract Refract Surg. 2015;41(8):1716–1724. DOI:10.1016/j.jcrs.2014.12.061
   PubMed Web of Science ®Google Scholar
• Falkenberry S, Singh IP, Crane CJ, et al. Excisional goniotomy vs trabecular microbypass stent implantation: a prospective randomized clinical trial in eyes with mild to moderate open-angle glaucoma. J Cataract Refract Surg. 2020;46(8):1165–1171. DOI:10.1097/j.jcrs.0000000000000229
   PubMed Web of Science ®Google Scholar
• Lewis RA, von Wolff K, Tetz M, et al. Canaloplasty: circumferential viscodilation and tensioning of Schlemm’s canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: interim clinical study analysis. J Cataract Refract Surg. 2007;33(7):1217–1226. DOI:10.1016/j.jcrs.2007.03.051
   PubMed Web of Science ®Google Scholar
• Yang SA, Mitchell W, Hall N, et al. Trends and usage patterns of minimally invasive glaucoma surgery in the United States: iRIS® registry analysis 2013-2018. Ophthalmol Glaucoma. 2021 Nov;4(6):558–568.
   PubMedGoogle Scholar
• Klabe K, Kaymak H. Standalone trabeculotomy and viscodilation of schlemm’s canal and collector channels in open-angle glaucoma using the OMNI surgical system: 24-month outcomes. Clin Ophthalmol. 2021;15:3121–3129.
   PubMed Web of Science ®Google Scholar
• Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget Impact Analysis—Principles of Good Practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value Health. 2014;17(1):5–14. DOI:10.1016/j.jval.2013.08.2291
   PubMed Web of Science ®Google Scholar
• Cantor L, Lindfield D, Ghinelli F, et al. Systematic literature review of clinical, economic, and humanistic outcomes following minimally invasive glaucoma surgery or selective laser trabeculoplasty for the treatment of open-angle glaucoma with or without cataract extraction. Clin Ophthalmol. 2023;17:85–101. doi: 10.2147/OPTH.S389406
   PubMed Web of Science ®Google Scholar
• Market Scope. Q3 - 2021 analysis of historical trends and latest developments. US Glaucoma Quarterly Update. 2021. https://www.market-scope.com/pages/reports/279/us-glaucoma-quarterly-update-q3-2021.
   Google Scholar
• CMS. Centers for Medicare & Medicaid Services (CMS) tariffs - January 2022. Available at: https://www.cms.gov/medicare/medicare-fee-for-service-payment/ascpayment/11_addenda_updates
   Google Scholar
• CMS. Centers for Medicare & Medicaid Services (CMS) tariffs - January 2022. Available at: https://www.cms.gov/Medicare/Medicare-Fee-For-Service-Payment/HospitalOutpatientpps/Addendum-A-and-Addendum-B-Updates
   Google Scholar
• CMS. Centers for Medicare & Medicaid Services (CMS) tariffs - January 2022. Available at: https://www.cms.gov/medicare/physician-fee-schedule/search
   Google Scholar
• Samuelson TW, Sarkisian SR Jr., Lubeck DM, et al. Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmol. 2019;126(6):811–821. DOI:10.1016/j.ophtha.2019.03.006
   PubMed Web of Science ®Google Scholar
• Paletta Guedes RA, Gravina DM, Paletta Guedes VM, et al. Two-Year Comparative Outcomes of First- and Second-Generation Trabecular Micro-Bypass Stents with Cataract Surgery. Clinical Ophthalmology. 2021;15:1861–1873. (Auckland, NZ).
   PubMed Web of Science ®Google Scholar
• Fea AM, Ahmed II, Lavia C, et al. Hydrus microstent compared to selective laser trabeculoplasty in primary open angle glaucoma: one year results. Clin Exp Ophthalmol. 2017;45(2):120–127. DOI:10.1111/ceo.12805
   PubMed Web of Science ®Google Scholar
• Jones J, Koch DD, Vold S, et al. Results from the United States cohort of the HORIZON trial of a Schlemm canal microstent to reduce intraocular pressure in primary open-angle glaucoma. J Cataract Refract Surg. 2019;45(9):1305–1315. DOI:10.1016/j.jcrs.2019.03.024
   PubMed Web of Science ®Google Scholar
• Shih V, Parekh M, Multani JK, et al. Clinical and economic burden of glaucoma by disease severity: a United States claims-based analysis. Ophthalmol Glaucoma. 2021;4(5):490–503. DOI:10.1016/j.ogla.2020.12.007
   PubMedGoogle Scholar
• Khawaja AP, Campbell JH, Kirby N, et al. Real-world outcomes of selective laser trabeculoplasty in the United Kingdom. Ophthalmol. 2020;127(6):748–757. DOI:10.1016/j.ophtha.2019.11.017
   PubMed Web of Science ®Google Scholar
• Barton K, Au L, Bouchet C, et al. Budget impact of a supra-ciliary micro-stent in both stand-alone surgery and in combination with cataract surgery for primary open-angle glaucoma from a UK secondary care perspective. Value In Health. 2017;20(9):A576. DOI:10.1016/j.jval.2017.08.1010
   Web of Science ®Google Scholar
• Martínez-de-la-Casa JM, Amaro-Barra A, Teus MA, et al. Budget impact analysis of the XEN® gel stent implant for glaucoma treatment. Expert Rev Ophthalmol. 2019;14(1):5–13. DOI:10.1080/17469899.2018.1560264
   Web of Science ®Google Scholar
• Longo R, Ghinelli F, Torelli F, et al. OMNI® Surgical System versus iStent Inject® with concomitant cataract surgery for the treatment of mild-to-moderate primary open-angle glaucoma in the United States: a cost utility analysis. Expert Rev Ophthalmol. 2023;1–8.
   Web of Science ®Google Scholar
• Cantor LB, Chapman R, Garcia K, et al. Glaucoma medication use in patients with a moderate glaucoma severity after receiving minimally invasive glaucoma surgery: an Academy IRIS® Registry analysis. American Glaucoma Society (AGS) Annual Meeting, March 2-5, Austin, TX. 2023.
   Google Scholar
• Mbagwu M, Chapman R, Garcia K, et al. A clinical registry study of glaucoma medication use in patients with mild glaucoma severity after MIGS. American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting, May 5-8. San Diego, CA. 2023. https://ascrs.confex.com/ascrs/23am/meetingapp.cgi/Paper/90326
   Google Scholar